[EN] COMPOUNDS AS HEPATITIS C INHIBITORS AND USES THEREOF IN MEDICINE<br/>[FR] COMPOSÉS UTILISÉS EN TANT QU'INHIBITEURS DU VIRUS DE L'HÉPATITE C ET LEURS UTILISATIONS EN MÉDECINE
申请人:SUNSHINE LAKE PHARMA CO LTD
公开号:WO2016127859A1
公开(公告)日:2016-08-18
Provided herein are compounds as hepatitis C inhibitors and uses thereof in medicine. Specifically, provided herein is a compound of Formula (I) or a stereoisomer, a tautomer, an enantiomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or hepatitis C diseases. Also provided herein are a pharmaceutically acceptable composition containing such compound and a method of treating HCV infection or hepatitis C diseases comprising administering the compound or pharmaceutical composition thereof disclosed herein.
本文提供了一些作为丙型肝炎抑制剂的化合物及其在医学上的用途。具体来说,本文提供了一种式(I)的化合物或其立体异构体、互变异构体、对映体、N-氧化物、水合物、溶剂合物、代谢物、药学上可接受的盐或其前药,可用于治疗HCV感染或丙型肝炎疾病。本文还提供了一种含有该化合物的药学上可接受的组合物,以及一种治疗HCV感染或丙型肝炎疾病的方法,包括给予本文所披露的化合物或药物组合物。